News Lugano/Bern,September 7th, 2018
UNITED STATES OF AMERICA AMBASSADOR EDWARD T. MCMULLEN VISITS CERBIOS-PHARMA SA
On September 7, Cerbios was honored by the visit of the US Ambassador to Switzerland and Liechtenstein, Edward McMullen Jr.
Aim of the visit of the Ambassador was to meet Cerbios’ top management and shareholder in order to have a better view and understanding of Cerbios’ ongoing and future activities in the USA.
Cerbios is active in the USA since 1982 with an established leadership with its reduced folates products used in oncology. In the past years, Figure 1 From left to right: Gabriel Haering (CEO), Edward McMullen Jr. (US Ambassador), Anton van Troostenburg activities have strongly increased as service (Chairman), Rudolf Dudler (Chemholding Chairman), Sandor Galambos (US Embassy)
provider and CDMO (Contract Development and Manufacturing Operation) for originators needing Cerbios’ expertise and know-how in handling and producing High Potency Active Ingredients (HPAIs) of the newest generation.
confirms Gabriel Haering, Cerbios’ CEO.
Figure 2 Ambassador Edward McMullen Jr. visiting the R&D labs with Claudio Pozzoli (Chief Scientific Office)
www.cerbios.swiss Page 1 Cerbios-Pharma SA
Via Figino 6 Phone : +41 (0) 91 985 63 11 CH – 6527 Barbengo/Lugano (TI) Fax : +41 (0) 91 985 63 25 Switzerland
says Ambassador McMullen. “It is our goal to support Cerbios and other Swiss companies in strengthening their activities in the United States”.
For more information please contact:
Media contact : [email protected]
About Cerbios-Pharma SA Cerbios is a private company with its headquarters in Lugano, Switzerland, specialized in developing and producing active pharmaceutical ingredients (APIs), both chemical and biological, for its clients around the world. Cerbios is a world leader for some generic products used primarily to treat respiratory, dermatological and oncological diseases.
Cerbios also offers its clients an exclusive service to develop and produce highly active pharmaceutical ingredients (HAPIs) and biological monoclonal antibody tablets, recombinant proteins, conjugated monoclonal antibodies (ADCs) and probiotics for pharmaceutical use.
Cerbios is capable of offering a complete service to develop and register pharmaceutical products, tablets supplied for clinical research phases, the necessary regulatory documentation and subsequent marketing supplies. Cerbios products are marketed around the entire world, primarily in the USA, Japan and Europe.
www.cerbios.swiss Page 2 Cerbios-Pharma SA
Via Figino 6 Phone : +41 (0) 91 985 63 11 CH – 6527 Barbengo/Lugano (TI) Fax : +41 (0) 91 985 63 25 Switzerland